Ventilator-associated lung injury: A search for better therapeutic targets

European Respiratory Journal

Volumn 30, Issue 6, 2007, Pages 1216-1226

  Oeckler, R A ^a   Hubmayr, R D ^a  

^a MAYO CLINIC   (United States)

Author keywords

Acute lung injury; Acute respiratory distress syndrome; Biomarker; Mechanisms; Treatment; Ventilator associated lung injury

Indexed keywords

APOCYNIN; BIOLOGICAL MARKER; MEPREDNISONE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ADULT RESPIRATORY DISTRESS SYNDROME; APOPTOSIS; ARTIFICIAL VENTILATION; BAROTRAUMA; BLOOD CLOTTING; CELL REGENERATION; CLINICAL TRIAL; HUMAN; IMMUNE RESPONSE; LUNG INJURY; MEDICAL LITERATURE; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

ANIMALS; APOPTOSIS; BLOOD COAGULATION; HUMANS; LUNG DISEASES; NEUTROPHILS; VENTILATORS, MECHANICAL; WOUND HEALING;

EID: 38849137297     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.00104907     Document Type: Review

References (131)

1. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967; 2: 319-323.
2. Masi A, Belisario C, Vecchi C. The respiratory distress syndrome (RDS) in the premature infant. Riv Clin Pediatr 1965; 76: 260-285.
3. McLaughlin JS, Suddhimondala C, Mech KF, et al. Pulmonary function in human shock. Surg Forum 1968; 19: 43-46.
4. Lucas CE, Ross M, Wilson RF. Physiologic shunting in the lungs in shock or trauma. Surg Forum 1968; 19: 35-37.
5. Harrison LH Jr, Beller JJ, Gill CC, Hinshaw LB, Coalson JJ, Greenfield LJ. Effects of endotoxin on pulmonary capillary permeability and surfactant. Surg Forum 1968; 19: 250-251.
6. Keller CA, Schramel RJ, Hyman AL, Creech O Jr. The cause of acute congestive lesions of the lung. J Thorac Cardiovasc Surg 1967; 53: 743-753.
7. Cahill JM, Jouasset-Strieder D, Byrne JJ. Lung function in shock. Am J Surg 1965; 110: 324-329.
8. Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-824.
9. Greenfield LJ, Ebert PA, Benson DW. Atelectasis and surface tension properties of lung extracts following positive pressure ventilation and overinflation. Surg Forum 1963; 14: 239-240.
10. Gattinoni L, Pesenti A. The concept of "baby lung". Intensive Care Med 2005; 31: 776-784.
11. Gattinoni L, Pesenti A, Bombino M, Pelosi P, Brazzi L. Role of extracorporeal circulation in adult respiratory distress syndrome management. New Horiz 1993; 1: 603-612.
12. 2 removal in severe acute respiratory failure. JAMA 1986; 256: 881-886.
13. 2. Lancet 1980; 2: 292-294.
14. Zapol WM, Snider MT, Hill JD, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 1979; 242: 2193-2196.
15. Browdie DA, Deane R, Shinozaki T, et al. Adult respiratory distress syndrome (ARDS), sepsis, and extracorporeal membrane oxygenation (ECMO). J Trauma 1977; 17: 579-586.
16. Gille JP, Bagniewski AM. Ten years of use of extracorporeal membrane oxygenation (ECMO) in the treatment of acute respiratory insufficiency (ARI). Trans Am Soc Artif Intern Organs 1976; 22: 102-109.
17. Thourani VH, Kirshbom PM, Kanter KR, et al. Venoarterial extracorporeal membrane oxygenation (VA-ECMO) in pediatric cardiac support. Ann Thorac Surg 2006; 82: 138-144; discussion 144-135.
18. Totapally BR, Sussmane JB, Torbati D, et al. Cardiovascular stability during arteriovenous extracorporeal therapy: a randomized controlled study in lambs with acute lung injury. Crit Care 2004; 8: R495-R503.
19. Santiago A, Ramos I, Quintana C. Extracorporeal membrane oxygenation: successful bridge to pediatric heart transplantation. P R Health Sci J 2004; 23: 59-63.
20. Gold JP, Torres KE, Maldarelli W, Zhuravlev I, Condit D, Wasnick J. Improving outcomes in coronary surgery: the impact of echo-directed aortic cannulation and perioperative hemodynamic management in 500 patients. Ann Thorac Surg 2004; 78: 1579-1585.
21. Dreyfuss D, Soler P, Basset G, Saumon G. High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis 1988; 137: 1159-1164.
22. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342: 1301-1308.
23. Petrucci N, Iacovelli W. Ventilation with lower tidal volumes versus traditional tidal volumes in adults for acute lung injury and acute respiratory distress syndrome. Cochrane Database Syst Rev 2003; CD003844.
24. Artigas A, Bernard GR, Carlet J, et al. The American-European Consensus Conference on ARDS, part 2: ventilatory, pharmacologic, supportive therapy, study design strategies, and issues related to recovery and remodeling. Acute respiratory distress syndrome. Am J Respir Crit Care Med 1998; 157: 1332-1347.
25. Dreyfuss D, Saumon G. Evidence-based medicine or fuzzy logic: what is best for ARDS management? Intensive Care Med 2002; 28: 230-234.
26. Zaas AK, Schwartz DA. Innate immunity and the lung: defense at the interface between host and environment. Trends Cardiovasc Med 2005; 15: 195-202.
27. Vercelli D. Innate immunity: sensing the environment and regulating the regulators. Curr Opin Allergy Clin Immunol 2003; 3: 343-346.
28. Lambrecht BN, Prins JB, Hoogsteden HC. Lung dendritic cells and host immunity to infection. Eur Respir J 2001; 18: 692-704.
29. Zhang P, Summer WR, Bagby GJ, Nelson S. Innate immunity and pulmonary host defense. Immunol Rev 2000; 173: 39-51.
30. Diamond G, Legarda D, Ryan LK. The innate immune response of the respiratory epithelium. Immunol Rev 2000; 173: 27-38.
31. Mannie MD. Immunological self/nonself discrimination: integration of self vs nonself during cognate T cell interactions with antigen-presenting cells. Immunol Res 1999; 19: 65-87.
32. Oldstone MB. Molecular mimicry and immune-mediated diseases. FASEB J 1998; 12: 1255-1265.
33. Putterman C, Limpanasithikul W, Edelman M, Diamond B. The double edged sword of the immune response: mutational analysis of a murine anti-pneumococcal, anti-DNA antibody. J Clin Invest 1996; 97: 2251-2259.
34. Clynes R, Ravetch JV. Cytotoxic antibodies trigger inflammation through Fc receptors. Immunity 1995; 3: 21-26.
35. Sprent J, Kosaka H. T cell tolerance and self/nonself discrimination. Autoimmunity 1993; 15: 155-161.
36. Hines WH, Haverty TP, Elias JA, Neilson EG, Kelly CJ. T cell recognition of epithelial self. Autoimmunity 1989; 5: 37-47.
37. Azoulay E, Darmon M, Delclaux C, et al. Deterioration of previous acute lung injury during neutropenia recovery. Crit Care Med 2002; 30: 781-786.
38. Abraham E. Neutrophils and acute lung injury. Crit Care Med 2003; 31: Suppl. 4, S195-S199.
39. Doerschuk CM, Allard MF, Martin BA, MacKenzie A, Autor AP, Hogg JC. Marginated pool of neutrophils in rabbit lungs. J Appl Physiol 1987; 63: 1806-1815.
40. Imanaka H, Shimaoka M, Matsuura N, Nishimura M, Ohta N, Kiyono H. Ventilator-induced lung injury is associated with neutrophil infiltration, macrophage activation, and TGF-β 1 mRNA upregulation in rat lungs. Anesth Analg 2001; 92: 428-436.
41. Reutershan J, Ley K. Bench-to-bedside review: acute respiratory distress syndrome - how neutrophils migrate into the lung. Crit Care 2004; 8: 453-461.
42. Choudhury S, Wilson MR, Goddard ME, O'Dea KP, Takata M. Mechanisms of early pulmonary neutrophil sequestration in ventilator-induced lung injury in mice. Am J Physiol Lung Cell Mol Physiol 2004; 287: L902-L910.
43. Kirchner EA, Mols G, Hermle G, et al. Reduced activation of immunomodulatory transcription factors during positive end-expiratory pressure adjustment based on volume-dependent compliance in isolated perfused rabbit lungs. Br J Anaesth 2005; 94: 530-535.
44. Toth I, Leiner T, Mikor A, Szakmany T, Bogar L, Molnar Z. Hemodynamic and respiratory changes during lung recruitment and descending optimal positive end-expiratory pressure titration in patients with acute respiratory distress syndrome. Crit Care Med 2007; 35: 787-793.
45. Girgis K, Hamed H, Khater Y, Kacmarek RM. A decremental PEEP trial identifies the PEEP level that maintains oxygenation after lung recruitment. Respir Care 2006; 51: 1132-1139.
46. Reis Miranda D, Gommers D, Struijs A, et al. Ventilation according to the open lung concept attenuates pulmonary inflammatory response in cardiac surgery. Eur J Cardiothorac Surg 2005; 28: 889-895.
47. Parsons PE, Eisner MD, Thompson BT, et al. Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury. Crit Care Med 2005; 33: 1-6; discussion 230-232.
48. Tamura DY, Moore EE, Partrick DA, Johnson JL, Offner PJ, Silliman CC. Acute hypoxemia in humans enhances the neutrophil inflammatory response. Shock 2002; 17: 269-273.
49. Haitsma JJ, Uhlig S, Verbrugge SJ, Goggel R, Poelma DL, Lachmann B. Injurious ventilation strategies cause systemic release of IL-6 and MIP-2 in rats in vivo. Clin Physiol Funct Imaging 2003; 23: 349-353.
50. Bregeon F, Roch A, Delpierre S, et al. Conventional mechanical ventilation of healthy lungs induced proinflammatory cytokine gene transcription. Respir Physiol Neurobiol 2002; 132: 191-203.
51. Schutte H, Lohmeyer J, Rosseau S, et al. Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema. Eur Respir J 1996; 9: 1858-1867.
52. Hippenstiel S, Witzenrath M, Schmeck B, et al. Adrenomedullin reduces endothelial hyperpermeability. Circ Res 2002; 91: 618-625.
53. Takao Y, Mikawa K, Nishina K, Obara H. Attenuation of acute lung injury with propofol in endotoxemia. Anesth Analg 2005; 100: 810-816.
54. Amigues L, Klouche K, Massanet P, et al. Sirolimus-associated acute respiratory distress syndrome in a renal transplant recipient. Transplant Proc 2005; 37: 2830-2831.
55. Montero AJ, McCarthy JJ, Chen G, Rice L. Acute respiratory distress syndrome after rituximab infusion. Int J Hematol 2005; 82: 324-326.
56. Lutz W, Stetkiewicz J. High mobility group box 1 protein as a late-acting mediator of acute lung inflammation. Int J Occup Med Environ Health 2004; 17: 245-254.
57. Baumgarten G, Knuefermann P, Wrigge H, et al. Role of Toll-like receptor 4 for the pathogenesis of acute lung injury in Gram-negative sepsis. Eur J Anaesthesiol 2006; 23: 1041-1048.
58. Yeh CC, Kao SJ, Lin CC, Wang SD, Liu CJ, Kao ST. The immunomodulation of endotoxin-induced acute lung injury by hesperidin in vivo and in vitro. Life Sci 2007; 80: 1821-1831.
59. Pespeni M, Mackersie RC, Lee H, et al. Serum levels of Hsp60 correlate with the development of acute lung injury after trauma. J Surg Res 2005; 126: 41-47.
60. Liszewski MK, Atkinson JP. Novel complement inhibitors. Expert Opin Investig Drugs 1998; 7: 323-331.
61. Bengsch S, Boos KS, Nagel D, Seidel D, Inthorn D. Extracorporeal plasma treatment for the removal of endotoxin in patients with sepsis: clinical results of a pilot study. Shock 2005; 23: 494-500.
62. Haase M, Silvester W, Uchino S, et al. A pilot study of high-adsorption hemofiltration in human septic shock. Int J Artif Organs 2007; 30: 108-117.
63. Morgera S, Klonower D, Rocktaschel J, et al. TNF-α elimination with high cut-off haemofilters: a feasible clinical modality for septic patients? Nephrol Dial Transplant 2003; 18: 1361-1369.
64. Uchino S, Bellomo R, Morimatsu H, et al. Cytokine dialysis: an ex vivo study. Asaio J 2002; 48: 650-653.
65. Toft P, Brix-Christensen V, Baech J, et al. Effect of hemodiafiltration and sepsis on chemotaxis of granulocytes and the release of IL-8 and IL-10. Acta Anaesthesiol Scand 2002; 46: 138-144.
66. Braun N, Rosenfeld S, Giolai M, et al. Effect of continuous hemodiafiltration on IL-6, TNF-α, C3a, and TCC in patients with SIRS/septic shock using two different membranes. Contrib Nephrol 1995; 116: 89-98.
67. Bellomo R, Tipping P, Boyce N. Interleukin-6 and interleukin-8 extraction during continuous venovenous hemodiafiltration in septic acute renal failure. Ren Fail 1995; 17: 457-466.
68. Bellomo R, Tipping P, Boyce N. Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993; 21: 522-526.
69. Wang L, Bastarache JA, Wickersham N, Fang X, Matthay MA, Ware LB. Novel role of the human alveolar epithelium in regulating intra-alveolar coagulation. Am J Respir Cell Mol Biol 2007; 36: 497-503.
70. Maybauer MO, Maybauer DM, Fraser JF, et al. Recombinant human activated protein C improves pulmonary function in ovine acute lung injury resulting from smoke inhalation and sepsis. Crit Care Med 2006; 34: 2432-2438.
71. Ware LB, Bastarache JA, Wang L. Coagulation and fibrinolysis in human acute lung injury - new therapeutic targets? Keio J Med 2005; 54: 142-149.
72. Jesmin S, Gando S, Matsuda N, et al. Temporal changes in pulmonary expression of key procoagulant molecules in rabbits with endotoxin-induced acute lung injury: elevated expression levels of protease-activated receptors. Thromb Haemost 2004; 92: 966-979.
73. He XL, Liu Z, Xia SY. Vascular endothelial injuries and changes of blood coagulation and fibrinolysis indexes in patients with acute respiratory distress syndrome. Chin Med Sci J 2004; 19: 252-256.
74. Prabhakaran P, Ware LB, White KE, Cross MT, Matthay MA, Olman MA. Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury. Am J Physiol Lung Cell Mol Physiol 2003; 285: L20-L28.
75. Laterre PF, Wittebole X, Dhainaut JF. Anticoagulant therapy in acute lung injury. Crit Care Med 2003; 31: Suppl. 4, S329-S336.
76. Welty-Wolf KE, Carraway MS, Idell S, Ortel TL, Ezban M, Piantadosi CA. Tissue factor in experimental acute lung injury. Semin Hematol 2001; 38: Suppl. 4, S35-S38.
77. Kinasewitz GT, Yan SB, Basson B, et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative microorganism [ISRCTN74215569]. Crit Care 2004; 8: R82-R90.
78. Russell JA. Genetics of coagulation factors in acute lung injury. Crit Care Med 2003; 31: Suppl. 4, S243-S247.
79. Bryant AE. Biology and pathogenesis of thrombosis and procoagulant activity in invasive infections caused by group A streptococci and Clostridium perfringens. Clin Microbiol Rev 2003; 16: 451-462.
80. Schiffer ER, Reber G, De Moerloose P, Morel DR. Evaluation of unfractionated heparin and recombinant hirudin on survival in a sustained ovine endotoxin shock model. Crit Care Med 2002; 30: 2689-2699.
81. Idell S. Adult respiratory distress syndrome: do selective anticoagulants help? Am J Respir Med 2002; 1: 383-391.
82. Opal SM. Clinical impact of novel anticoagulation strategies in sepsis. Curr Opin Crit Care 2001; 7: 347-353.
83. Xu H, Ploplis VA, Castellino FJ. A coagulation factor VII deficiency protects against acute inflammatory responses in mice. J Pathol 2006; 210: 488-496.
84. Schultz MJ, Haitsma JJ, Zhang H, Slutsky AS. Pulmonary coagulopathy as a new target in therapeutic studies of acute lung injury or pneumonia - a review. Crit Care Med 2006; 34: 871-877.
85. Robriquet L, Collet F, Tournoys A, et al. Intravenous administration of activated protein C in Pseudomonas-induced lung injury: impact on lung fluid balance and the inflammatory response. Respir Res 2006; 7: 41.
86. Kipnis E, Guery BP, Tournoys A, et al. Massive alveolar thrombin activation in Pseudomonas aeruginosa-induced acute lung injury. Shock 2004; 21: 444-451.
87. Bastarache J, Wang L, Geiser T, et al. The alveolar epithelium can initiate the extrinsic coagulation cascade through expression of tissue factor. Thorax 2007; 62: 608-616.
88. Pittet JF, Mackersie RC, Martin TR, Matthay MA. Biological markers of acute lung injury: prognostic and pathogenetic significance. Am J Respir Crit Care Med 1997; 155: 1187-1205.
89. Chesnutt AN, Matthay MA, Tibayan FA, Clark JG. Early detection of type III procollagen peptide in acute lung injury. Pathogenetic and prognostic significance. Am J Respir Crit Care Med 1997; 156: 840-845.
90. Chapman HA, Yang XL, Sailor LZ, Sugarbaker DJ. Developmental expression of plasminogen activator inhibitor type 1 by human alveolar macrophages. Possible role in lung injury. J Immunol 1990; 145: 3398-3405.
91. Guzik TJ, Channon KM. Measurement of vascular reactive oxygen species production by chemiluminescence. Methods Mol Med 2005; 108: 73-89.
92. Tarpey MM, Wink DA, Grisham MB. Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations. Am J Physiol Regul Integr Comp Physiol 2004; 286: R431-R444.
93. Takenaka K, Nishimura Y, Nishiuma T, et al. Ventilator-induced lung injury is reduced in transgenic mice that overexpress endothelial nitric oxide synthase. Am J Physiol Lung Cell Mol Physiol 2006; 290: L1078-L1086.
94. Choi WI, Quinn DA, Park KM, et al. Systemic microvascular leak in an in vivo rat model of ventilator-induced lung injury. Am J Respir Crit Care Med 2003; 167: 1627-1632.
95. Frank JA, Wray CM, McAuley DF, Schwendener R, Matthay MA. Alveolar macrophages contribute to alveolar barrier dysfunction in ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol 2006; 291: L1191-L1198.
96. Zapol WM. Minidose inhaled nitric oxide: less is better. Intensive Care Med 1993; 19: 433-434.
97. Gerlach H, Pappert D, Lewandowski K, Rossaint R, Falke KJ. Long-term inhalation with evaluated low doses of nitric oxide for selective improvement of oxygenation in patients with adult respiratory distress syndrome. Intensive Care Med 1993; 19: 443-449.
98. McQuaid KE, Keenan AK. Endothelial barrier dysfunction and oxidative stress: roles for nitric oxide? Exp Physiol 1997; 82: 369-376.
99. Oeckler RA, Wolin MS. New concepts in vascular nitric oxide signaling. Curr Atheroscler Rep 2000; 2: 437-444.
100. Chapman KE, Sinclair SE, Zhuang D, Hassid A, Desai LP, Waters CM. Cyclic mechanical strain increases reactive oxygen species production in pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 2005; 289: L834-L841.
101. Oeckler RA, Kaminski PM, Wolin MS. Stretch enhances contraction of bovine coronary arteries via an NAD(P)H oxidase-mediated activation of the extracellular signal-regulated kinase mitogen-activated protein kinase cascade. Circ Res 2003; 92: 23-31.
102. Usatyuk PV, Vepa S, Watkins T, He D, Parinandi NL, Natarajan V. Redox regulation of reactive oxygen species-induced p38 MAP kinase activation and barrier dysfunction in lung microvascular endothelial cells. Antioxid Redox Signal 2003; 5: 723-730.
103. Wang W, Suzuki Y, Tanigaki T, Rank DR, Raffin TA. Effect of the NADPH oxidase inhibitor apocynin on septic lung injury in guinea pigs. Am J Respir Crit Care Med 1994; 150: 1449-1452.
104. Suzuki Y, Tanigaki T, Heimer D, et al. Polyethylene glycol-conjugated superoxide dismutase attenuates septic lung injury in guinea pigs. Am Rev Respir Dis 1992; 145: 388-393.
105. Baboolal HA, Ichinose F, Ullrich R, Kawai N, Bloch KD, Zapol WM. Reactive oxygen species scavengers attenuate endotoxin-induced impairment of hypoxic pulmonary vasoconstriction in mice. Anesthesiology 2002; 97: 1227-1233.
106. Kjaeve J, Ingebrigtsen T, Naess L, Bjertnaes L, Vaage J. Methylprednisolone attenuates airway and vascular responses induced by reactive oxygen species in isolated, plasma-perfused rat lungs. Free Radic Res 1996; 25: 407-414.
107. Rahman I, Kelly F. Biomarkers in breath condensate: a promising new non-invasive technique in free radical research. Free Radic Res 2003; 37: 1253-1266.
108. Dunican AL, Leuenroth SJ, Grutkoski P, Ayala A, Simms HH. TNFα-induced suppression of PMN apoptosis is mediated through interleukin-8 production. Shock 2000; 14: 284-288; discussion 288-289.
109. Petrache I, Verin AD, Crow MT, Birukova A, Liu F, Garcia JG. Differential effect of MLC kinase in TNF-α-induced endothelial cell apoptosis and barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 2001; 280: L1168-L1178.
110. Yoshikawa S, King JA, Lausch RN, Penton AM, Eyal FG, Parker JC. Acute ventilator-induced vascular permeability and cytokine responses in isolated and in situ mouse lungs. J Appl Physiol 2004; 97: 2190-2199.
111. Fujita M, Kuwano K, Kunitake R, et al. Endothelial cell apoptosis in lipopolysaccharide-induced lung injury in mice. Int Arch Allergy Immunol 1998; 117: 202-208.
112. Krunkosky TM, Fischer BM, Akley NJ, Adler KB. Tumor necrosis factor α (TNF α)-induced ICAM-1 surface expression in airway epithelial cells in vitro: possible signal transduction mechanisms. Ann NY Acad Sci 1996; 796: 30-37.
113. Husain KD, Stromberg PE, Javadi P, et al. Bcl-2 inhibits gut epithelial apoptosis induced by acute lung injury in mice but has no effect on survival. Shock 2003; 20: 437-443.
114. Alvira CM, Abate A, Yang G, Dennery PA, Rabinovitch M. Nuclear factor-κB activation in neonatal mouse lung protects against lipopolysaccharide-induced inflammation. Am J Respir Crit Care Med 2007; 175: 805-815.
115. de Souza PM, Lindsay MA. Apoptosis as a therapeutic target for the treatment of lung disease. Curr Opin Pharmacol 2005; 5: 232-237.
116. Genovese T, Mazzon E, Di Paola R, et al. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and the development of bleomycin-induced lung injury. J Pharmacol Exp Ther 2005; 313: 529-538.
117. Jin Y, Choi AM. Cytoprotection of heme oxygenase-1/carbon monoxide in lung injury. Proc Am Thorac Soc 2005; 2: 232-235.
118. St Croix CM, Leelavaninchkul K, Watkins SC, Kagan VE, Pitt BR. Nitric oxide and zinc homeostasis in acute lung injury. Proc Am Thorac Soc 2005; 2: 236-242.
119. Standiford TJ, Keshamouni VG, Reddy RC. Peroxisome proliferator-activated receptor-γ as a regulator of lung inflammation and repair. Proc Am Thorac Soc 2005; 2: 226-231.
120. Suzuki T, Moraes TJ, Vachon E, et al. Proteinase-activated receptor-1 mediates elastase-induced apoptosis of human lung epithelial cells. Am J Respir Cell Mol Biol 2005; 33: 231-247.
121. Bingisser R, Stey C, Weller M, Groscurth P, Russi E, Frei K. Apoptosis in human alveolar macrophages is induced by endotoxin and is modulated by cytokines. Am J Respir Cell Mol Biol 1996; 15: 64-70.
122. Goodman ER, Stricker P, Velavicius M, et al. Role of granulocyte-macrophage colony-stimulating factor and its receptor in the genesis of acute respiratory distress syndrome through an effect on neutrophil apoptosis. Arch Surg 1999; 134: 1049-1054.
123. Matute-Bello G, Liles WC, Radella F 2nd, et al, Modulation of neutrophil apoptosis by granulocyte colony-stimulating factor and granulocyte/macrophage colony-stimulating factor during the course of acute respiratory distress syndrome. Crit Care Med 2000; 28: 1-7.
124. Thickett DR, Armstrong L, Christie SJ, Millar AB. Vascular endothelial growth factor may contribute to increased vascular permeability in acute respiratory distress syndrome. Am J Respir Crit Care Med 2001; 164: 1601-1605.
125. Gillette MA, Hess DR. Ventilator-induced lung injury and the evolution of lung-protective strategies in acute respiratory distress syndrome. Respir Care 2001; 46: 130-148.
126. Dreyfuss D, Saumon G. Ventilator-induced lung injury: lessons from experimental studies. Am J Respir Crit Care Med 1998; 157: 294-323.
127. Dreyfuss D, Basset G, Soler P, Saumon G. Intermittent positive-pressure hyperventilation with high inflation pressures produces pulmonary microvascular injury in rats. Am Rev Respir Dis 1985; 132: 880-884.
128. Gajic O, Lee J, Doerr CH, Berrios JC, Myers JL, Hubmayr RD. Ventilator-induced cell wounding and repair in the intact lung. Am J Respir Crit Care Med 2003; 167: 1057-1063.
129. Vlahakis NE, Hubmayr RD. Cellular stress failure in ventilator-injured lungs. Am J Respir Crit Care Med 2005; 171: 1328-1342.
130. Vlahakis NE, Schroeder MA, Pagano RE, Hubmayr RD. Deformation-induced lipid trafficking in alveolar epithelial cells. Am J Physiol Lung Cell Mol Physiol 2001; 280: L938-L946.
131. Eur Respir J 2007; 30: 1227-1230